| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.31B | 133.70B | 118.51B | 105.54B | 112.91B | 107.90B |
| Gross Profit | 46.60B | 46.45B | 39.47B | 34.86B | 38.76B | 35.13B |
| EBITDA | 18.05B | 18.66B | 14.77B | 12.68B | 15.51B | 13.34B |
| Net Income | 10.63B | 11.10B | 8.57B | 7.02B | 9.35B | 7.62B |
Balance Sheet | ||||||
| Total Assets | 154.63B | 168.28B | 158.67B | 151.94B | 149.00B | 140.31B |
| Cash, Cash Equivalents and Short-Term Investments | 55.17B | 47.52B | 46.61B | 48.96B | 48.75B | 52.10B |
| Total Debt | 0.00 | 150.00M | 0.00 | 0.00 | 13.00M | 38.00M |
| Total Liabilities | 27.48B | 38.25B | 33.51B | 35.30B | 37.10B | 36.19B |
| Stockholders Equity | 126.04B | 128.84B | 123.64B | 114.94B | 110.25B | 102.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.31B | 793.00M | 2.17B | -635.00M | 11.60B |
| Operating Cash Flow | 0.00 | 11.55B | 3.28B | 5.19B | 3.56B | 15.83B |
| Investing Cash Flow | 0.00 | -7.09B | -2.66B | -2.61B | -4.87B | -4.34B |
| Financing Cash Flow | 0.00 | -7.47B | -2.85B | -2.47B | -2.29B | -2.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥81.59B | 8.04 | ― | 0.82% | 7.10% | 36.47% | |
78 Outperform | ¥62.70B | 8.62 | ― | 3.69% | 4.46% | 127.52% | |
76 Outperform | ¥265.94B | 14.78 | ― | 2.42% | 9.55% | 9.52% | |
73 Outperform | ¥2.69T | 19.24 | 8.35% | 1.77% | 5.39% | 4.89% | |
73 Outperform | ¥155.36B | 14.99 | ― | 1.39% | 11.23% | 16.49% | |
64 Neutral | ¥637.51B | 16.50 | ― | 2.14% | 7.73% | 30.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |